Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.34 |
| ▸ | MMP12 | P39900 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23947816 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL23947812 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL21192256 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL21192230 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL23947803 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL24264030 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL24264431 | 1.00 | KDM4E (0.41) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL21192077 | 0.99 | KDM4E (0.40) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL21189477 | 0.99 | KDM4E (0.42) | KDM4EATML3MBTL1CHEK2PTGER4 | |
| SCHEMBL21215344 | 0.99 | KDM4E (0.42) | KDM4EATML3MBTL1CHEK2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| WO-2022025714-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323948-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, UBE2L3, OPRL1 | KDM4E 3842/4885ATM 2218/4885L3MBTL1 94/4885 |
| US-11873297-B2 | Compound and organic light emitting device comprising the same | CCNL2, UBE2L3, ARL1 | KDM4E 3695/4885ATM 2154/4885L3MBTL1 83/4885 |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | KDM4E 2372/4885ATM 2759/4885L3MBTL1 1309/4885 |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, CYP1A1 | KDM4E 3655/4885ATM 2369/4885L3MBTL1 1106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.